INDEX VALUES   |

Home > Our Indexes > LSCIBC

Download Methodology

LifeSci Biotechnology Clinical Trials Index


The LifeSci Biotechnology Clinical Trials Index ("LSCIBC") is an equal weighted index that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering that is in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development. The inception date for LSCIBC was November 3, 2014.

LSCIBCS&P 500
Prior Day Closing Value4286.084771.02
Prior Day Change %+0.07%-0.59%
Current Value
Current Day Change %-0.25%+1.51%
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume

Index Characteristics (Nov 20, 2017)


No. of Constituents 73
Total Market Cap ($ in millions) 0
Mean Market Cap ($ in millions) 0
Median Market Cap ($ in millions) 0
Largest Constituent ($ in millions) 0
Smallest Constituent ($ in millions) 0

Market Cap Breakdown (Nov 20, 2017)


Top 10 Constituents (Nov 20, 2017)


Constituent Ticker Weight
Anaptysbio Inc ANAB 3.68%
Myokardia Inc MYOK 2.98%
Juno Therapeutics Inc JUNO 2.89%
Dynavax Technologies Corp DVAX 2.55%
Beigene Ltd-adr BGNE 2.42%
Arena Pharmaceuticals Inc ARNA 2.24%
Sangamo Therapeutics Inc SGMO 2.22%
Insmed Inc INSM 2.17%
Aimmune Therapeutics Inc AIMT 2.14%
Ignyta Inc RXDX 2.07%
Data Updated Daily
Download All Constituents